Royalty Pharma plc - Ordinary Shares - Class A

NASDAQ:RPRX  
37.67
-1.21 (-3.11%)
Earnings Announcements

Royalty Pharma Reports Third Quarter 2021 Results

Published: 11/10/2021 12:23 GMT
Royalty Pharma plc - Ordinary Shares - Class A (RPRX) - Royalty Pharma Reports Third Quarter 2021 Results.
Royalty Pharma - Anticipates 2021 Adjusted Cash Receipts to Be Between $2,110 Million and $2,130 Million.
Revenue is expected to be $545.56 Million
Adjusted EPS is expected to be $0.78

Next Quarter Revenue Guidance is expected to be $605.03 Million
Next Quarter EPS Guidance is expected to be $0.72

More details on our Analysts Page.